Idinvest Partners and Aurinvest, as well as existing backer Kurma Life Sciences Partners (KLS), have injected €3.8m into Paris-based biotechnology firm Pathoquest.
De Scorbiac was responsible for the Accenture Venture fund's activities in Europe
GP sells the Dutch employment agency to its CEO, ending its three-years ownership
Financing for the acquisition was provided by Santander Corporate and Commercial Banking
Sussex Place Ventures, Contour Ventures, Partnership Fund and Outrun Ventures also take part